Balversa 4 MG
Ended Awarded
- Contract number
- 36C24524N0912
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,643
Award facts
- Contract value 100% obligated
- $17,642.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., is for the delivery of the cancer treatment drug BALVERSA 4 MG. The award, with a ceiling value of $17,642.95, is a firm fixed price delivery order placed under a larger $3.1 billion multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the Department of Veterans Affairs (VA).
The contract has an ultimate completion date of September 13, 2024 and was awarded on September 12, 2024 to the prime contractor, Janssen Biotech, a for-profit pharmaceutical manufacturer. This delivery order is placed against a $3.7 million Blanket Purchase Agreement (BPA) established in August 2020, which allows VHA buying offices to efficiently procure BALVERSA and other oncology medications. The contract does not have a set-aside designation, reflecting Janssen's status as a large commercial supplier. These critical drug deliveries support the VA's comprehensive healthcare services for veterans across the country.
Quick answers
Who was awarded contract 36C24524N0912?
36C24524N0912 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 12, 2024.
How much is contract 36C24524N0912 worth?
The government has obligated $17,643 on 36C24524N0912.
Is contract 36C24524N0912 an order under another contract?
Yes. 36C24524N0912 is a delivery order under 36F79724D0176, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0912 competed?
The extent of competition for 36C24524N0912 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award